Petition Update

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C ge

Margaret Dudley
San Antonio, TX

May 3, 2014 — http://www.aidsmap.com/page/2847422/

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6
Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6
A new experimental NS5A inhibitor, GS-5816, was shown to be safe and effective when used in an interferon- and ribavirin-free dual regimen with sofosbuvir (Sovaldi) for people with hepatitis C genotypes 1 through 6, according to phase 2 trial results presented at the 49th annual meeting of the European Association for the Study of the Liver (EASL) last week in London.
http://www.aidsmap.com